A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone

BACKGROUND: Cardiac pathological hypertrophy is associated with a significantly increased risk of coronary heart disease and has been observed in diabetic patients treated with rosiglitazone whereas most published studies do not suggest a similar increase in risk of cardiovascular events in pioglita...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Verschuren, Lars, Wielinga, Peter Y, Kelder, Thomas, Radonjic, Marijana, Salic, Kanita, Kleemann, Robert, van Ommen, Ben, Kooistra, Teake
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4072889/
https://ncbi.nlm.nih.gov/pubmed/24938300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1755-8794-7-35
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller